Lv1
70 积分 2025-10-09 加入
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
10天前
已完结
Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review
10天前
已完结
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
10天前
已完结
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma
10天前
已完结
GPRC5D as a novel immunotherapeutic target in multiple myeloma
15天前
已完结
Directional Engineering of Cyclic β-Hairpin Peptides for PET/CT Imaging of PD-L1
1个月前
已完结
Introduction to Neurogenetics
1个月前
已关闭
Genomic complexity of multiple myeloma and its clinical implications
3个月前
已完结
AI-driven 3D Spatial Transcriptomics
7个月前
已完结
皖公网安备34019202002308
